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INTRODUCTION
The ketogenic diet (KD), is an effective treatment for intracta-
ble childhood epilepsy, such as West syndrome (WS), Lennox-
Gastaut syndrome, and sometimes for refractory status epi-
lepticus.1 The use of this treatment, however, is sometimes 
limited due to its complications, despite of the efficacy. While 
some side effects are benign and treatable, others are more 
problematic and rarely can interrupt the diet therapy itself.2-4 
Protein-losing enteropathy (PLE) is a rarely recognized seri-
ous complication of the KD, and only two cases have been re-
ported.5,6
We experienced one case of PLE during the KD in a 16 month 
old male Down syndrome baby with WS.
CASE REPORT
A 16-month-old male baby was diagnosed with Down syn-
drome by chromosome analysis and clinical features after 
birth. He presented epileptic spasms since the age of 5 months 
and was diagnosed with WS. He started to be treated by mul-
tiple antiepileptic drugs (AEDs), including vigabatrin, cloba-
zam, valproic acid and oral steroids, but his epileptic seizures, 
developmental regression, and hypsarrhythmia on electroen-
cephalogram persisted.
KD with 3:1 ratio of fat to non-fat was started by milk formu-
la, and multiple AEDs (vigabatrin, clobazam, and deflazacort) 
were maintained at the same doses. Vomiting and diarrhea 
were developed after 1st week of KD. The albumin level which 
was 3.8 g/dL at initiation of the diet decreased to 1.8 g/dL after 
16 days of KD. He was treated by intravenous albumin and in-
termittent parenteral nutritional support. Lipid and non-fat 
ratio of KD deescalated from 2:1 on the 28th days to 1.7:1 on 
the 30th days of the diet. Because he had not improved after 4 
weeks, we changed KD to medium chain triglyceride formula 
on the 61st days of the diet.
Laboratory tests, abdominal ultrasonography, esophago-
gastroduodenoscopy (EGD), colonoscopy, and alpha-1 anti-
trypsin (A1AT) in stool, were done. There was no proteinuria 
in urine dipstick test, and blood test revealed blood urea ni-
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trogen 9.2 mg/dL, creatinine 0.2 mg/dL, aspartate aminotrans-
ferase 16 IU/L, alanine aminotrasnferase 5 IU/L, and normal 
thyroid function. Echocardiography revealed normal heart 
function without any structural abnormalities. There were no 
pathogens in stool bacterial culture, but norovirus infection 
was detected in stool virus study. Abdominal ultrasonography 
revealed grossly normal liver and gallbladder, and preserved 
corticomedullary differentiation in both kidneys, and there 
was no skin lesions that could produce protein loss. 
EGD revealed edematous mucosa in the duodenum, and 
the biopsy results revealed lymphatic ectasia in the lamina 
propria; thus intestinal lymphangiectasia was diagnosed (Fig. 
1). A1AT of the stool was 56.60 mg/dL. These findings were 
concordant with interstitial lymphangiectasia as a presenta-
tion of PLE.
We discontinued the KD after 8 weeks and supported him 
with balanced nutrition. His general condition improved, and 
hypoalbuminemia, edema, and diarrhea were resolved after 
cessation of KD (Fig. 2).
DISCUSSION
With increasing use of KD, more early and late complications 
have recently been reported. Kang, et al.2 and Suo, et al.3 showed 
that hypoproteinemia is commonly appeared on KD with ap-
Fig. 1. Edematous mucosa and some whitish patches were noted on the duodenum. Slightly edematous gastric mucosa was also noted. Biopsies were 
acquired from the duodenum and the stomach. Pathology result: ectatic lymphatics in lamina propria, suspicious for intestinal lymphangiectasia.
HOD2 HOD8 HOD10 HOD16 HOD19 HOD24 HOD28 HOD30
Total protein (g/dL) 5.7 5.2 4.2 3.1 4.1 4.0 4.2 3.9
Albumin (g/dL) 3.8 3.6 3.0 1.8 2.8 2.7 2.5 2.6
Diarrhea - - - + + + + +
Ketogenic diet 3:1 2:1 1.7:1
Evaluation Stool culture
virus study
US
TFT
Parental nutrition
Albumin replacement
HOD43 HOD51 HOD61 HOD73 HOD75 HOD79 HOD81 HOD85
Total protein (g/dL) 3.3 4.2 4.4 3.9 5.0 5.1 6.6
Albumin (g/dL) 1.7 2.6 2.7 2.8 3.5 3.2 4.1
Diarrhea + + + - - - -
Ketogenic diet MCT General diet
Evaluation A1AT EGD, echo
Albumin replacement
Fig. 2. Scheme of ketogenic diet, nutritional support, evaluation and laboratory data. On HOD2, the ketogenic diet (3:1, fat:non-fat) was started. diar-
rhea and hypoalbuminemia occurred. through laboratory test, we checked normal renal function, liver function, normal flora in stool culture and nor-
oviral infection confirmed in viral study on HOD16. And parental nutrition and albumin replacement were started. abdominal ultrasonography and 
thyroid function test were normal on HOD19. On HOD28, the ketogenic diet was reduced from 3:1 to 1.7:1. The symptoms were persistent, and after 
EGD and echocardiography on HOD61, the ketogenic diet was stopped, and a MCT was started. HOD, hospitalization day; US, abdominal ultrasonog-
raphy; TFT, thyroid function test; MCT, medium chain triglycerides; A1AT, alpha-1 antitrympsin; EGD, endoscopic gastroduodenoscopy; echo, echo-
cardiography; MCT, medium chain triglyceride diet.
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proximately 10% of the patients: 12 of 129 patients (9.3%) and 
39 of 317 patients (12.3%), respectively. Gluconeogenic con-
sumption due to restriction of carbohydrate and reduced pro-
tein intake were suspected as mechanism of hypoproteinemia. 
Patients with hypoproteinemia can be improved by increase of 
protein intake with maintenance of lipid-to-nonlipid ratio.4
Gastrointestinal (GI) disturbance, common early and late 
complication of KD, is related to poor tolerance of the diet and 
it can disturb the maintenance and efficacy of KD. The symp-
toms of GI disturbance were seen in 73 (56.6%) patients, re-
ported by Kang, et al.4 Transient GI disturbances are explained 
by defective absorption and intolerance of high-lipid diet, there 
fore, adaptation periods seem to be required.
Hypoproteinemia and diarrhea as early complications of 
KD are expected to be controlled by well-known conservative 
cares. However, patients with abnormal progression, for ex-
ample persistent symptoms, or who need intravenous replace-
ment of protein continuously, have to undergo further evalua-
tion for other causes including PLE. 
In most cases, PLE can be diagnosed by history, physical ex-
amination and clinical manifestations, nevertheless, docu-
mentation of GI losses of protein by fecal A1AT levels or with 
functional imaging is necessary.7,8
There are two main mechanisms of PLE-mucosal injury or 
lymphatic abnormalities, sometimes both of them together.8-10 
Mucosal injury is caused by variety of conditions-inflamma-
tory or ulcerative diseases, such as infections, Crohn’s dis-
ease/ulcerative colitis or GI malignancies, and other non-ul-
cerative diseases. Intestinal lymphangiectasia is characterized 
by diffuse or local dilatation of the enteric lymphatics and 
leakage of lymphatic fluid rich in albumin and other proteins 
into the GI tract. Increased leakage of protein-rich fluids across 
damaged mucosa can cause loss of protein, and mucosal cell 
injury is related to secondary lymphangiectasia. Abnormality 
of the lymphatic drainage can be caused by either congenital 
defect as primary intestinal lymphangiectasia or by secondary 
causes as GI obstruction, congestive heart failure, lymphoma 
and other intestinal damage. 
Norovirus infection is a major cause of GI disturbance in 
children. Fecal shedding of norovirus persists for up to 2 weeks, 
however, it can persist for up to 5 weeks in immune-compro-
mised patient.11 Furthermore, norovirus infection is associat-
ed with exacerbation of inflammatory bowel disease.12 How-
ever, there is no definite relationship between noroviral infection 
and PLE. In this case, immune-compromised status due to 
taking steroid for long times could have made GI tract inflam-
mation worse.
There have been two published case reports of PLE upon 
initiation of the KD-one case was explained by allergic gastro-
enteritis from a soy allergy,4 and the other case seemed to have 
been caused by the diet itself.5 Mucosal injury by viral infection 
and secondary lymphangiectasia which was aggravated by KD 
itself are highly suspected mechanism of PLE in our case.
PLE, a rarely experienced serious complication of the KD, 
can interrupt the maintenance of diet therapy. Early detection 
and active intervention are important in maintaining the health 
of such patients.
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